These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 20208002

  • 21. Poly(ADP-ribose) polymerase-1 inhibitor modulates T regulatory and IL-17 cells in the prevention of adjuvant induced arthritis in mice model.
    Ahmad SF, Zoheir KM, Bakheet SA, Ashour AE, Attia SM.
    Cytokine; 2014 Aug; 68(2):76-85. PubMed ID: 24845796
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3.
    Zhang P, Maruyama T, Konkel JE, Abbatiello B, Zamarron B, Wang ZQ, Chen W.
    PLoS One; 2013 Aug; 8(8):e71590. PubMed ID: 23977081
    [Abstract] [Full Text] [Related]

  • 24. c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells.
    Visekruna A, Huber M, Hellhund A, Bothur E, Reinhard K, Bollig N, Schmidt N, Joeris T, Lohoff M, Steinhoff U.
    Eur J Immunol; 2010 Mar; 40(3):671-6. PubMed ID: 20049877
    [Abstract] [Full Text] [Related]

  • 25. Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction.
    Ishimaru N, Yamada A, Kohashi M, Arakaki R, Takahashi T, Izumi K, Hayashi Y.
    J Immunol; 2008 May 15; 180(10):6997-7008. PubMed ID: 18453622
    [Abstract] [Full Text] [Related]

  • 26. Egress of mature murine regulatory T cells from the thymus requires RelA.
    Fukazawa T, Hiraiwa N, Umemura T, Mise-Omata S, Obata Y, Doi T.
    J Immunol; 2015 Apr 01; 194(7):3020-8. PubMed ID: 25725099
    [Abstract] [Full Text] [Related]

  • 27. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A, Zhang B, Qu Y, Zhang A, Sun C, Zhang L, Liu J, Zeng C, Zhao Y.
    Transpl Immunol; 2009 Mar 01; 20(4):253-60. PubMed ID: 19146957
    [Abstract] [Full Text] [Related]

  • 28. The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
    Aricha R, Feferman T, Scott HS, Souroujon MC, Berrih-Aknin S, Fuchs S.
    J Autoimmun; 2011 Feb 01; 36(1):16-24. PubMed ID: 21035305
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.
    Ahmad SF, Zoheir KM, Ansari MA, Korashy HM, Bakheet SA, Ashour AE, Al-Shabanah OA, Al-harbi MM, Attia SM.
    Mol Immunol; 2015 Feb 01; 63(2):394-405. PubMed ID: 25304310
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Foxp3 induction in human and murine thymus precedes the CD4+ CD8+ stage but requires early T-cell receptor expression.
    Nunes-Cabaço H, Ribot JC, Caramalho I, Serra-Caetano A, Silva-Santos B, Sousa AE.
    Immunol Cell Biol; 2010 Jul 01; 88(5):523-8. PubMed ID: 20142839
    [Abstract] [Full Text] [Related]

  • 33. Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation.
    Zaiss MM, Sarter K, Hess A, Engelke K, Böhm C, Nimmerjahn F, Voll R, Schett G, David JP.
    Arthritis Rheum; 2010 Aug 01; 62(8):2328-38. PubMed ID: 20506516
    [Abstract] [Full Text] [Related]

  • 34. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
    Zhao L, Sun L, Wang H, Ma H, Liu G, Zhao Y.
    J Leukoc Biol; 2007 Jun 01; 81(6):1386-94. PubMed ID: 17369496
    [Abstract] [Full Text] [Related]

  • 35. Transplanting of mesenchymal stem cells may affect proliferation and function of CD4(+)T cells in experimental autoimmune encephalomyelitis.
    Zhu J, Zhang J, Li Q, Du Y, Qiao B, Hu X.
    Exp Clin Transplant; 2012 Oct 01; 10(5):492-500. PubMed ID: 22817386
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells.
    Dahlberg PE, Schartner JM, Timmel A, Seroogy CM.
    Clin Exp Immunol; 2007 Aug 01; 149(2):226-34. PubMed ID: 17490400
    [Abstract] [Full Text] [Related]

  • 38. Impact of systemic histamine deficiency on the crosstalk between mammary adenocarcinoma and T cells.
    Hegyesi H, Colombo L, Pállinger E, Tóth S, Boer K, Molnár V, Falus A.
    J Pharmacol Sci; 2007 Sep 01; 105(1):66-73. PubMed ID: 17895589
    [Abstract] [Full Text] [Related]

  • 39. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY.
    Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692
    [Abstract] [Full Text] [Related]

  • 40. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.
    Ghali JR, Alikhan MA, Holdsworth SR, Kitching AR.
    Immunology; 2017 Jan 05; 150(1):100-114. PubMed ID: 27606831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.